 | • レポートコード：MRC2203A618 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の高度視覚化市場規模が予測期間中に年平均11.3％成長すると予測しています。本調査資料では、高度視覚化の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品・サービス別（ハードウェア、ソフトウェア、サービス）分析、ソリューション別（企業、単独）分析、画像モダリティ別（MRI、CT、超音波、核医療、その他）分析、臨床用途別（腫瘍、整形外科、心血管、神経、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の高度視覚化市場規模：製品・サービス別（ハードウェア、ソフトウェア、サービス） ・世界の高度視覚化市場規模：ソリューション別（企業、単独） ・世界の高度視覚化市場規模：画像モダリティ別（MRI、CT、超音波、核医療、その他） ・世界の高度視覚化市場規模：臨床用途別（腫瘍、整形外科、心血管、神経、その他） ・世界の高度視覚化市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（AGFA-Gevaert N.V.、Canon Medical Systems、Carestream Health, Inc.、...） ・市場機会・将来の傾向 |
The advanced visualization market is expected to register a CAGR of 11.3% over the forecast period. The major factors for the growth of the market include the increasing prevalence of chronic diseases coupled with growing geriatric population, and rising awareness of benefits associated with advanced visualization tools in disease diagnosis.
According to the United States Census Bureau’s Statistics as of 2017, the total number of people aged 65 and older had exceeded 50 million, and between 2020-2030 the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 and older is expected to be more than triple from an estimated 6 million currently to nearly 20 million by 2060. The rise in geriatric population will increase the patient pool suffering from various chronic diseases and advanced visualization tools are expected to increase the correct diagnosis rate among the patients. Hence, the market is expected to witness high growth.
Key Market Trends
Oncology Segment by Clinical Application is Expected to Witness High Growth over the Forecast Period
The major factors driving growth of the market includes rising technological advancements and increase in the adoption of the advanced visualization tools in healthcare facilitites. Furhermore, the rising prevalence of various types of cancer is expected to boost the demand for advanced visualization systems over the forecast period. The global cancer burden is increasing, and thus, cancer therapies must be modified according to regional and national priorities. According to the World Cancer Research Fund, in 2018, there were an estimated 18 million cancer cases around the world, out of which, 9.5 million cases were in men and 8.5 million in women.
Also, major market players are launching new products in the market. For instance, in Febrauary 2019, Philips announced the launch of IntelliSpace Portal 11, which is an advanced visualization and quantification software.
Thus, considering all the above mentioned factors the market is expected to witness high CAGR over the forecast period.
North America is Expected to hold a Significant Market Share over the Forecast Period
North America expected to hold a major market share in the global advanced visualization market due to increasing cases of chronic diseases and presence of better healthcare infrastructure. Information systems have tremendous potential in reducing healthcare costs and improving outcomes. These systems play a major role, not only in reducing costs but also in improving the accurate diagnosis. In the United States most of the hospitals are focusing on providing the value-based care. The advanced visualization systems are expected to help healthcare providers to do the same. Hence, the market is expected to witness high growth over the forecast period.
Competitive Landscape
The advanced visualization market is moderately consolidated market. Some of the market players in advanced visualization market are AGFA-Gevaert N.V., Canon Medical Systems, Carestream Health, Inc., Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., PRO Medicus Limited, Siemens Healthineers, and Terarecon, Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases Coupled With Growing Geriatric Population
4.2.2 Rising Awareness of Benefits associated with Advanced Visualization Tools in Disease Diagnosis
4.3 Market Restraints
4.3.1 Limited Availability of Reimbursements for Radiology-Based Diagnostic Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product & Service
5.1.1 Hardware
5.1.2 Software
5.1.3 Services
5.2 By Type of Solution
5.2.1 Enterprise
5.2.2 Standalone
5.3 By Imaging Modality
5.3.1 Magnetic Resonance Imaging (MRI)
5.3.2 Computed Tomography (CT)
5.3.3 Ultrasound
5.3.4 Nuclear Medicine
5.3.5 Other
5.4 By Clinical Application
5.4.1 Oncology
5.4.2 Orthopedics
5.4.3 Cardiovascular
5.4.4 Neurology
5.4.5 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AGFA-Gevaert N.V.
6.1.2 Canon Medical Systems
6.1.3 Carestream Health, Inc.
6.1.4 Fujifilm Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Koninklijke Philips N.V.
6.1.7 PRO Medicus Limited
6.1.8 Siemens Healthineers
6.1.9 Terarecon, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS